Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies
{{output}}
The discovery of EGFR mutations two decades ago launched an era of rapid development and clinical application of targeted therapies in NSCLC. Today, increasing numbers of targeted therapies against somatic aberrations involving nine different genes have become... ...
